KIMBERLY CONNALLY: Open Payments
NPI 1487856092 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,411 in 143 payments from 20 companies in 2025. Trend: 2023 $1,812 · 2024 $4,454 · 2025 $4,411
Food & beverage: $3,228Consulting: $1,140Education: $43
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 33 | $1,776 |
| Regeneron Healthcare Solutions, Inc. | 16 | $562 |
| Amgen Inc. | 14 | $538 |
| ABBVIE INC. | 19 | $265 |
| Novartis Pharmaceuticals Corporation | 13 | $195 |
| Lilly USA, LLC | 5 | $180 |
| Ferring Pharmaceuticals Inc. | 2 | $158 |
| Galderma Laboratories, L.P. | 13 | $152 |
| PFIZER INC. | 5 | $103 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $85 |
Products named: Bimzelx, DUPIXENT, OTEZLA, ADSTILADRIN, COSENTYX, NEMLUVIO, SKYRIZI, RINVOQ.
Industry payments across GA — which companies pay providers there.
